Orchestra Biomed Holdings Inc (OBIO)

Apr 04, 2025

Where Orchestra BioMed Hldgs Stands With Analysts - Benzinga

Apr 04, 2025

Apr 04, 2025

H.C. Wainwright cuts Orchestra BioMed stock target to $12 By Investing.com - Investing.com UK

Apr 04, 2025

Apr 04, 2025

Health Check: How Prudently Does Orchestra BioMed Holdings (NASDAQ:OBIO) Use Debt? - simplywall.st

Apr 04, 2025

Apr 03, 2025

HighTower Advisors LLC Has $274,000 Stock Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

Apr 03, 2025

Apr 03, 2025

Orchestra BioMed (NASDAQ:OBIO) Earns Buy Rating from Chardan Capital - Defense World

Apr 03, 2025

Apr 02, 2025

Orchestra BioMed Reports 2024 Financial Results and Advances Cardiovascular Therapy - MyChesCo

Apr 02, 2025

Apr 02, 2025

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q4 Loss, Lags Revenue Estimates - MSN

Apr 02, 2025

Apr 01, 2025

Orchestra BioMed (NASDAQ:OBIO) Posts Earnings Results, Hits Estimates - MarketBeat

Apr 01, 2025

Apr 01, 2025

BTIG maintains $12 target on Orchestra BioMed stock By Investing.com - Investing.com Canada

Apr 01, 2025

Apr 01, 2025

OBIO stock touches 52-week low at $3.63 amid market challenges By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

OBIO stock touches 52-week low at $3.63 amid market challenges - Investing.com Australia

Apr 01, 2025

Mar 31, 2025

Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update - The Manila Times

Mar 31, 2025

Mar 28, 2025

(OBIO) Trading Advice - news.stocktradersdaily.com

Mar 28, 2025

Mar 25, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Mar 25, 2025

Mar 24, 2025

Freightos And 2 Other Penny Stocks Worth Watching - simplywall.st

Mar 24, 2025

Mar 23, 2025

Orchestra BioMed (NASDAQ:OBIO) Research Coverage Started at BTIG Research - ETF Daily News

Mar 23, 2025

Mar 22, 2025

Orchestra BioMed (NASDAQ:OBIO) Coverage Initiated at BTIG Research - Defense World

Mar 22, 2025

Mar 20, 2025

BTIG Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Buy Recommendation - Nasdaq

Mar 20, 2025

Mar 20, 2025

BTIG sets Orchestra BioMed stock with $12 target By Investing.com - Investing.com Australia

Mar 20, 2025

Mar 20, 2025

Insiders In Orchestra BioMed Holdings Left Out From 10% Price Rise After Disposing Stock - simplywall.st

Mar 20, 2025

Mar 20, 2025

BTIG Initiates Orchestra BioMed at Buy With $12 Price Target -March 20, 2025 at 07:15 am EDT - Marketscreener.com

Mar 20, 2025

Mar 19, 2025

Orchestra BioMed (OBIO) Projected to Post Earnings on Wednesday - Defense World

Mar 19, 2025

Mar 11, 2025

Orchestra BioMed (NASDAQ:OBIO) Given Buy Rating at HC Wainwright - Defense World

Mar 11, 2025

Mar 10, 2025

H.C. Wainwright maintains $14 target on Orchestra BioMed stock By Investing.com - Investing.com South Africa

Mar 10, 2025

Mar 10, 2025

Promising Clinical Developments and Strategic Advancements Drive Buy Rating for Orchestra BioMed Holdings - TipRanks

Mar 10, 2025

Mar 07, 2025

Dr. Vivek Reddy Joins Orchestra BioMed to Lead Breakthrough Hypertension Study - MSN

Mar 07, 2025

Mar 03, 2025

Orchestra BioMed Highlights Strategic Initiatives and Innovations - TipRanks

Mar 03, 2025

Feb 26, 2025

Orchestra BioMed to Participate in Upcoming Investor Conferences - MSN

Feb 26, 2025

Feb 25, 2025

Orchestra BioMed Updates Executive Compensation Policies - TipRanks

Feb 25, 2025

Feb 22, 2025

Orchestra BioMed Welcomes Christopher Cleary to Board of Directors - MSN

Feb 22, 2025

Feb 20, 2025

Orchestra BioMed to Present at Upcoming Investor Conferences - GlobeNewswire

Feb 20, 2025

Feb 20, 2025

3 Major Healthcare Conferences Where Orchestra BioMed Will Share Its Growth Story - StockTitan

Feb 20, 2025

Feb 18, 2025

Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive - GlobeNewswire

Feb 18, 2025

Feb 18, 2025

Mount Sinai's Top Cardiac Expert Takes Helm of Groundbreaking Hypertension Treatment Study - StockTitan

Feb 18, 2025

Feb 17, 2025

Orchestra BioMed (NASDAQ:OBIO) Shares Up 5.1%Time to Buy? - MarketBeat

Feb 17, 2025

Feb 17, 2025

Orchestra BioMed Unveils Groundbreaking Data on AVIM Therapy’s Potential to Prevent Heart Failure - MSN

Feb 17, 2025

Feb 14, 2025

SG Americas Securities LLC Has $51,000 Stock Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

Feb 14, 2025

Feb 14, 2025

Orchestra BioMed (NASDAQ:OBIO) Trading 5.1% Higher – Here’s Why - Defense World

Feb 14, 2025

Feb 14, 2025

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Sees Large Decline in Short Interest - Defense World

Feb 14, 2025

Feb 13, 2025

How the (OBIO) price action is used to our Advantage - Stock Traders Daily

Feb 13, 2025

Feb 13, 2025

Individual investors among Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) largest stockholders and were hit after last week's 11% price drop - Simply Wall St

Feb 13, 2025

Feb 12, 2025

Orchestra BioMed Says AVIM Therapy Improves Echo Markers of Diastolic Dysfunction - Marketscreener.com

Feb 12, 2025

Feb 12, 2025

Orchestra BioMed Announces Data Demonstrating Favorable - GlobeNewswire

Feb 12, 2025

Feb 12, 2025

Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference - GlobeNewswire

Feb 12, 2025

Feb 12, 2025

Clinical Data: Orchestra BioMed's AVIM Therapy Shows Significant Heart Failure Prevention Benefits | OBIO Stock News - StockTitan

Feb 12, 2025